Average clinical outcomes determine FDA-approved dosages
Approved drug dosages may not be suitable for all patients, since they are often based on population-based efficacy and safety outcomes from clinical trials.
It is estimated that prescribed dosages are appropriate for only 40% of patients – those who are extensive (normal) metabolizers.
One size DOES NOT fit all.
* Based on phenotyoe distributionfor the CYP2C19 isoenzyme for clopidogrel
For more information on pharmacogenetic testing, contact:
PGx Medical
Individualized Care – Personalized Medicine
info@pgxmed.com
405-509-5112